These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10631465)

  • 1. The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Bishop MR; Tallman MS; Somerfield MR; Feinglass J; Smith TJ
    Ann Oncol; 1999 Nov; 10(11):1355-9. PubMed ID: 10631465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Smith TJ; Weeks JC; Bredt AB; Feinglass J; Fetting JH; Hillner BE; Somerfield MR; Winn RJ
    J Clin Oncol; 1996 Sep; 14(9):2511-20. PubMed ID: 8823330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Weeks JA; Somerfield MR; Feinglass J; Smith TJ
    J Clin Oncol; 1999 Nov; 17(11):3676-81. PubMed ID: 10550166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor usage patterns and outcomes in the community setting: collection through a practice-based computerized clinical information system.
    Swanson G; Bergstrom K; Stump E; Miyahara T; Herfindal ET
    J Clin Oncol; 2000 Apr; 18(8):1764-70. PubMed ID: 10764438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.
    Bennett CL; Stinson TJ; Laver JH; Bishop MR; Godwin JE; Tallman MS
    Leuk Lymphoma; 2000 Mar; 37(1-2):65-70. PubMed ID: 10721770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor practice patterns among pediatric oncologists: results of a 1998 Pediatric Oncology Group Survey. Economic Evaluation Working Group the Pediatric Oncology Group.
    Parsons SK; Mayer DK; Alexander SW; Xu R; Land V; Laver J
    J Pediatr Hematol Oncol; 2000; 22(3):227-41. PubMed ID: 10864054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.
    J Clin Oncol; 1994 Nov; 12(11):2471-508. PubMed ID: 7964965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
    Adams JR; Elting LS; Lyman GH; George JN; Lembersky BC; Armitage JO; Demetri GD; Bennett CL
    Am J Med; 2004 Jan; 116(1):28-34. PubMed ID: 14706663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of colony-stimulating factor use in US academic health centers.
    Yim JM; Matuszewski KA; Vermeulen LC; Ratko TA; Burnett DA; Vlasses PH
    Ann Pharmacother; 1995 May; 29(5):475-81. PubMed ID: 7544655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor use in cancer patients.
    Baker J; McCune JS; Harvey RD; Bonsignore C; Lindley CM
    Ann Pharmacother; 2000; 34(7-8):851-7. PubMed ID: 10928394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between introduction of American society of clinical oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital.
    Debrix I; Tilleul P; Milleron B; Grené N; Bouleuc C; Roux D; Lioté H; Madelaine I; Bellanger A; Conort O; Fontan JE; Le Mercier F; Bardin C; Becker A
    Clin Ther; 2001 Jul; 23(7):1116-27. PubMed ID: 11519774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cytokines in the treatment of acute myelocytic leukemia: a critical review.
    Geller RB
    J Clin Oncol; 1996 Apr; 14(4):1371-82. PubMed ID: 8648396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use.
    Barnes G; Pathak A; Schwartzberg L
    Cancer Med; 2014 Dec; 3(6):1477-84. PubMed ID: 25410813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
    Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Survey of Oncologists' Perceptions and Opinions Regarding the Use of Granulocyte Colony-Stimulating Factors.
    Hawkins A; Murphy A; McNamara M; Gawade PL; Belani R; Kelsh MA
    J Cancer Educ; 2020 Feb; 35(1):178-186. PubMed ID: 31656028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
    Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
    Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.